About the Belfer Institute
The Belfer Institute for Applied Cancer Science is a fully integrated, collaborative cancer research center dedicated to translating today’s most innovative oncology research into tomorrow’s most promising cancer treatments. This highly focused, goal-oriented organization represents a new academic construct that embeds an industrial approach within a premier academic setting. The Institute’s excellence in leading edge early-stage biology enables its scientists to define the best targets and the optimal clinical path for targeted cancer therapies. The Belfer Institute’s strategic collaborations with leading pharmaceutical companies are driving the development of a next generation of cancer therapies. The Belfer Institute is part of the Dana-Farber Cancer Institute and is affiliated with Harvard Medical School.
In the News
Study reports first success of targeted therapy in most common genetic subtype of non-small cell lung cancer